Safety and Immunogenicity of Three Formulations of Takeda's Tetravalent Dengue Vaccine Candidate (TDV)
Clinical trial NCT02193087 · COMPLETED
Trial details
- NCT number
- NCT02193087
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-06
- Primary completion
- 2015-05-19
- Enrollment
- 1002
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.